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Abstract
Background: Ankylosing spondylitis (AS) often has a long period from first symptom presentation to diagnosis. We
examined the occurrence of symptoms, prescriptions and diagnostic tests in primary care electronic records over
time prior to a diagnosis of AS.
Methods: Nested case-control study using anonymised primary care electronic health records from Scotland. Cases were
74 adults with a first diagnosis of AS between 2000 and 2010. Controls were matched for age, sex and GP practice: (a)
296 randomly selected adults (b) 169 adults whose records contained codes indicating spinal conditions or symptoms.
We extracted clinical features (symptoms, AS-related disorders, prescriptions and diagnostic tests). Conditional logistic
regression was used to examine the association between clinical features (both individually and in combinations) and
diagnosis of AS. We examined the associations between clinical features and diagnosis over time prior to diagnosis.
Results: Several new composite pointers were predictive of AS: including distinct episodes of axial pain separated by more
than 6months (OR 12.7, 95% CI 4.7 to 34.6); the occurrence of axial pain with and tendon symptoms within the same year
(OR 21.7, 95% CI 2.6 to 181.5); and the co-occurrence (within 30 days) of axial pain and a prescription for nonsteroidal anti-
inflammatory drug (OR 10.4, 95%CI 4.9 to 22.1). Coded episodes of axial pain increased steadily over the 3 years before
diagnosis. In contrast, large joint symptoms and enthesopathy showed little or no time trend prior to diagnosis.
Conclusions: We identified novel composite pointers to a diagnosis of AS in GP records. These may represent valuable
targets for diagnostic support systems.
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Background
Ankylosing Spondylitis (AS) is an uncommon rheumato-
logical condition in primary care, for which there is often
a long time between consultation and diagnosis [1, 2]. As
with other conditions in which a long period between first
consultation and diagnosis is often seen, symptoms of AS
(such as spinal pain, stiffness and fatigue) are both non-
specific and frequently occuring [2, 3]. This often leads to
primary care doctors assigning the symptoms of AS to
more common back pain conditions.
Most research on the clinical features of AS in primary
care has focused on the characteristics of back pain. In-
flammatory features such as worsening in the second
half of the night, causing stiffness on waking and relief
by exercise [4–8] have high sensitivity but relatively low
specificity for AS. We considered the possibility of using
data in electronic records to support earlier diagnosis of
AS. While records may include codes for back pain, they
do not currently include searchable information about
the characteristics of pain. However other features in
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: chris.burton@sheffield.ac.uk
3Academic Unit of Primary Medical Care, University of Sheffield, Samuel Fox
House, Northern General Hospital, Sheffield S5 7AU, UK
Full list of author information is available at the end of the article
Bashir et al. BMC Family Practice           (2020) 21:78 
https://doi.org/10.1186/s12875-020-01149-2
records may act as proxy markers for these pain chara-
teristics. For instance the association in time between
back pain and prescription of non-steroidal anti-
inflammatory drugs (NSAID) may suggest inflammatory
back pain (which often responds well to NSAIDs). While
such knowledge-derived features [9] are not immediately
present in electronic records, they can be constructed
[10, 11]. One very recent study has used machine learn-
ing based on single items in a clinical care database but
still found only low predictive values [12]..
We aimed to (a) construct enriched datasets from
electronic health records which contained conventional
and composite features potentially predictive of AS; (b)
examine the association of these features with a subse-
quent diagnosis of AS in a nested case-control study; (c)
examine the relationship of these features to diagnosis at
different time periods before the date of diagnosis.
Methods
Data source
We analysed data from the Practice Team Information
(PTI) database, a subset of the Primary Care Clinical In-
formatics Unit Research database held by the University
of Aberdeen. The PTI database is comprised of pseudo-
nymised electronic health records which were collected
between 1996 and 2010 from approximately 224,000 pa-
tients registered with a primary care physician in
Scotland. It is broadly representative of the Scottish
population with regards to age, sex, deprivation and geo-
graphical location in terms of the ratio of urban: rural
practices [13]. Practices which contributed their data to
the PTI project were expected to record every clinical
encounter using Read codes for clinical diagnoses and /
or, main reasons for consultation. Diagnostic codes en-
tered during and before the study dates were included in
the data. All GP prescriptions were automatically re-
corded throughout the database period. Procedures for
the routine recording and coding of diagnostic investiga-
tions changed over the database period as electronic
linkages between laboratories and GP practices devel-
oped. Investigations were present in the data more in
later years of the database period. The study was ap-
proved by the Primary Care Clinical Informatics Unit
(PCCIU) team in keeping with PCCIU and local ethical
committee procedures.
Populations
We conducted a nested case-control study. Cases were
patients whose first recorded diagnosis of AS was be-
tween 1/1/2000 and 31/12/2010 and who were aged be-
tween 18 and 50 years at the time of diagnosis. We
excluded patients whose first recorded diagnosis oc-
curred within 1 year of registering with their GP practice
as (a) it was possible that this represented the coding of
an earlier diagnosis for the purposes of updating record
summaries i.e. a prevalent rather than incident case of
AS (b) it did not allow sufficient period of time in which
relevant data before diagnosis could be examined for
features predictive of AS. We then excluded patients
who had been prescribed a disease modifying anti-
rheumatic drug (sulphasalazine or methotrexate) more
than 1month prior to their coded diagnosis. We did this
in order to ensure that our analysis was limited to inci-
dent cases rather than prevalent cases in whom an earl-
ier diagnosis had not been coded at the time it was
made.
Population controls who did not have a diagnosis of
AS at the index date were identified electronically from
the database for each case. Controls were individually
matched on age, sex and GP practice. Where more than
four matched controls were available for a given case the
computer randomly selected four. A second control
group comprised patients with codes for other spinal
diagnoses including degenerative, mechanical and inter-
vertebral disc disorders or for a symptom of axial pain,
but with no recorded diagnosis of AS. These controls
were also electronically selected for each case and indi-
vidually matched by age (within 2 years), sex and GP
practice, with up to four symptomatic controls per case.
We defined the index date for cases as the date of diag-
nosis of AS and for controls as the date of diagnosis of
AS in the matched case.
Data extraction and preparation
For all cases and controls, data were extracted which de-
tailed the dates of consultation for particular symptoms,
disorders, tests and procedures and drugs prescribed.
Table 1 lists the key data extracted and the categories
into which we grouped related items.
As well as examining various individual features e.g.
axial pain, we enriched the data by calculating when a
number of composite features had occurred e.g. axial
pain occurring within 30 days of a prescription for a
non-steroidal anti-inflammatory drug (NSAID). We spe-
cified composite features according to one of three rela-
tionships: proximity (where two features occurred within
a given number of days of each other), separate (where
two consecutive instances of the same features occurred
more than a given number of days apart), and exclusive
(where one code occurred and another was not present).
We used the separate composite features in order to
identify discrete episodes as opposed to a single episode
comprising multiple instances of a feature.
For each feature (single and composite) we ascertained
its presence in the record of each individual at any time
in the record, and during a series of overlapping three-
year time windows set at different intervals from the
index date (for diagnosis or matching). We defined the
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windows using intervals between the end of the window
and the index date of 0, 3, 6, 12, 18, 24 and 36months.
We then examined the appearance of statistical associa-
tions between available information in the record and
diagnosis over time by comparing the same measure in
different windows. The purpose of this was to differenti-
ate between features which were present long before
diagnosis (and might thus indicate missed diagnostic op-
portunities) and those which appeared only shortly be-
fore diagnosis (and may thus have triggered referral).
Analysis of association of features and patterns with
diagnosis
We carried out conditional logistic regression to exam-
ine the association between each feature (conventional
or composite) and the diagnosis of AS. Each feature was
reported as either present or absent within the time
period. Rather than use counts of how often a feature
occurred, we used the “separated” composite variables to
indicate multiple episodes. Analyses were reported as
the odds ratio, OR (with 95% confidence intervals, CI).
All analyses were conducted in R 3.6 [14].
We conducted the analysis separately with population
and symptomatic control groups. For the time window
analysis, we limited the data to patients who had been
registered with their practice for at least 1year before the
beginning of the relevant gap prior to diagnosis. We
plotted the odds ratios for each feature at each of the six
different time gaps in order to visualise the appearance
of predictive features over time.
Results
Patient characteristics
There were 74 newly diagnosed cases who met the study
criteria. The annual number of diagnoses was broadly
similar between 2000 and 2006 (representing an inci-
dence of approximately 4/100,000 registered patients per
year) but fell after 2006 – this coincided with a progres-
sive reduction in the size of the database as GP practice
computer systems were replaced.
Cases were matched to 296 population controls and
169 symptomatic controls. 53 cases (72%) were men and
median age at diagnosis of AS was 37 years (interquartile
range 31 to 43).
Data quality
54 cases (73%) were registered with the same GP prac-
tice (and therefore had continuous records in the PTI
database) for at least 6 years before diagnosis. Similar
proportions were seen for population and symptomatic
controls (81 and 72% respectively). A code for one or
more prescription of an appropriate treatment (e.g. a
NSAID) was present for 68 cases (92%). Diagnostic tests
were coded less often – any relevant diagnostic code
(such as for a full blood count, ESR or x-ray) was
present in only 30 cases (41%).
Table 1 Types of data extracted and categories which individual codes were mapped to
Data type Data type categories
Spinal symptoms and disorders Axial pain
Other spinal diagnoses e.g.cervical spondylosis, mechanical back pain
Sciaticaa
Musculoskeletal and AS- related features Enthesopathy and other tendon disorders
Large joint symptoms / disorders e.g. knee pain
Other joint symptoms / disorders e.g. foot pain
Iritis
Urethral symptoms
Fatigue
Other related disorders Inflammatory Bowel Disease
Inflammatory Arthritis (including psoriatic arthropathy)
Diagnostic tests and procedures Full blood count
Erythrocyte Sedimentation Rate (ESR)
Thyroid Functionb
X-ray (spine / pelvis)
Computerised Tomography
Magnetic Resonance Imaging
Treatments Non-steroidal anti-inflammatory drugs (NSAIDs)
Analgesics (up to codeine)
Opioids (tramadol and more potent)
Tricyclic antidepressantsc
Selective Serotonin Re-uptake Inhibitors (SSRI)d
aSciatica included to look for back pain in absence of sciatica
bThyroid function included as used in non-specific / fatigue work up
cTricylics are typically prescribed for chronic pain rather than for depression
dSSRIs are typically prescribed for anxiety or depression rather than for chronic pain
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Occurrence of diagnostic features
The numbers and proportions of patients with at least
one instance of each feature, either in the 3 years prior
to the index date or at any time are shown in Table 2
(vs. population controls) and Table 3 (vs. symptomatic
controls). Tables 2 & 3 also show the ORs (with 95%
CIs) for the two comparisons.
As expected axial pain was more common in cases than
population controls (OR 9.8, 95% CI 5.1 to 18.9) but not
than symptomatic controls (OR 1.0, 95% CI 0.6 to 1.8) in
the 3 years period before the index date. Tendon related
disorders and iritis were both more common in cases than
population controls (OR 3.4, 95% CI 1.3 to 8.7 and OR
32.0, 95% CI 4.0 to 255.9) but were recorded in only 21
and 16% of cases respectively. Urethral symptoms were in-
frequently recorded in all groups. Fatigue was not more
common in cases when compared to population and
symptomatic controls (OR 1.9, 95% CI 0.8 to 4.2 and 2.1,
95% CI 0.8 to 5.7) respectively. A history of inflammatory
bowel disease was present in 16% of cases at any time
before diagnosis. Codes indicating recording of x-rays and
MRI scans were rare among cases and controls.
Occurrence of prescribed treatments
In both the population and the symptomatic group com-
parisons, both analgesics (OR 6.0, 95% CI 3.3 to 10.8
and OR 2.0, 95% CI 1.1 to 3.6) and NSAIDS (OR 12.9,
95% CI 6.3 to 26.8 and OR 3.6, 95% CI 1.8 to 7.1) were
more commonly prescribed in the 3 year period before
the index date to cases than controls. Prescriptions of
tricyclic antidepressants, typically prescribed for chronic
pain, were more common compared to population con-
trols, unlike prescriptions for other antidepressants.
Composite features
Table 4 shows the number and proportion of patients
with at least one instance of each of the composite fea-
tures over the 3 years before date of diagnosis/ match-
ing. Several composite features appeared relatively
infrequently. Only three occurred in more than 15% of
Table 2 Numbers, proportions and odds ratios (95% CI) for features in cases of ankylosing spondylitis compared with population
controls
Occurrence of features in 3 years before index date Occurrence of features at any time before index date
Cases (N = 74) Controls (N = 296) Cases (N = 74) Controls (N = 296)
Specific features N % N % OR (95% CI) N % N % OR (95% CI)
Axial pain 39 52.7 31 10.5 9.8 (5.1, 18.9) 49 66.2 70 23.7 7.5 (4.0, 14.2)
Other spine diagnosis 16 21.6 17 5.7 5.1 (2.3, 11.3) 22 29.7 33 11.2 3.7 (1.9, 7.3)
Sciatica 5 6.8 8 2.7 2.8 (0.8, 9.3) 9 12.2 18 6.1 2.3 (0.9, 5.8)
Large joint symptom 14 18.9 25 8.5 2.7 (1.3, 5.8) 22 29.7 47 15.9 2.4 (1.3, 4.4)
Other joint symptom 5 6.8 4 1.4 6.0 (1.4, 25.5) 7 9.5 10 3.4 3.4 (1.2, 9.8)
Tendon disorders 9 12.2 12 4.1 3.4 (1.3, 8.7) 16 21.6 21 7.1 3.6 (1.7, 7.3)
Iritis 8 10.8 1 0.3 32.0 (4.0, 255.9) 12 16.2 3 1.0 16.0 (4.5, 56.7)
Urethral symptoms 2 2.7 1 0.3 – – 3 4.1 8 2.7 1.5 (0.4, 6.0)
Fatigue 10 13.5 24 8.1 1.9 (0.8, 4.2) 12 16.2 39 13.2 1.3 (0.6, 2.8)
Inflamm. Bowel disease 7 9.5 4 1.4 7.0 (2.1, 23.9) 12 16.2 13 4.4 4.9 (2.0, 12.3)
Other Inflamm. arthritis 3 4.1 2 0.7 – – 5 6.8 4 1.4 – –
X-ray spine 6 8.1 0 0.0 – – 7 9.5 2 0.7 – –
X-ray pelvis 2 2.7 0 0.0 – – 2 2.7 0 0.0 – –
Full Blood Count 12 16.2 19 6.4 5.5 (1.8, 16.4) 15 20.3 23 7.8 9.2 (2.5, 33.4)
ESR 6 8.1 5 1.7 14.9 (1.7, 127.8) 7 9.5 6 2.0 9.7 (2.0, 47.9)
MRI scan 0 0.0 2 0.7 – – 0 0.0 3 1.0 – –
NSAIDs 52 70.3 60 20.3 12.9 (6.3, 26.8) 57 77.0 93 31.4 13.3 (5.9, 29.9)
Analgesics 37 50.0 43 14.5 6.0 (3.3, 10.8) 41 55.4 73 24.7 4.4 (2.4, 7.8)
Opioids 8 10.8 5 1.7 7.5 (2.2, 25.0) 10 13.5 8 2.7 7.9 (2.4, 25.7)
Tricyclic antidepressants 10 13.5 15 5.1 2.9 (1.3, 6.8) 12 16.2 18 6.1 3.2 (1.4, 7.3)
SSRI antidepressants 5 6.76 33 11.2 0.56 (0.2, 1.5) 12 16.22 13 4.39 4.91 (2.0, 12.3)
Features: Large Joint symptom codes relating to large limb joints (shoulder-wrist, hip-ankle); Other joint symptoms codes relating to joints distal to wrist/ ankle; ESR
Erythrocyte sedimentation rate, MRI Magentic resonance imaging, NSAID Non-steroidal anti-inflammatory drugsm, Analgesics paracetamol, codeine; Opioids opioid
drugs of the potency of tramadol or higher, SSRI Selective Serotonin Reuptake Inhibitor & related antidepressants; Index date: date of diagnosis for cases, date of
diagnosis of matched case for controls
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Table 3 Numbers, proportions and odds ratios (95% CI) for features in cases of ankylosing spondylitis compared with symptomatic
controls
Occurrence of features in 3 years before index date Occurrence of features at any time before index date
Cases (N = 74) Controls (N = 169) Cases (N = 74) Controls (N = 169)
Specific features N % N % OR (95% CI) N % N % OR (95% CI)
Axial pain 39 52.7 93 55.0 1.0 (0.6, 1.8) 49 66.2 146 86.4 0.3 (0.2, 0.6)
Other spine diagnosis 16 21.6 25 14.8 1.8 (0.8, 3.9) 22 29.7 40 23.7 1.4 (0.7, 2.7)
Sciatica 5 6.8 19 11.2 0.6 (0.2, 1.7) 9 12.2 31 18.3 0.7 (0.3, 1.4)
Large joint symptom 14 18.9 14 8.3 2.1 (0.9, 4.8) 22 29.7 34 20.1 1.5 (0.8, 2.9)
Other joint symptom 5 6.8 4 2.4 2.7 (0.6, 12.5) 7 9.5 6 3.6 2.8 (0.8, 10.3)
Tendon disorders 9 12.2 10 5.9 2.1 (0.8, 5.5) 16 21.6 21 12.4 1.7 (0.8, 3.6)
Iritis 8 10.8 0 0.0 – – 12 16.2 0 0.0 – –
Urethral symptoms 2 2.7 1 0.6 – – 3 4.1 4 2.4 1.5 (0.3, 6.8)
Fatigue 10 13.5 14 8.3 2.1 (0.8, 5.7) 12 16.2 22 13.0 1.3 (0.5, 3.1)
Inflamm. Bowel disease 7 9.5 2 1.2 12.0 (1.5, 99.4) 12 16.2 9 5.3 3.2 (1.3, 7.8)
Other Inflamm. arthritis 3 4.1 2 1.2 – – 5 6.8 4 2.4 2.5 (0.7, 9.5)
X-ray spine 6 8.1 2 1.2 12.6 (1.5, 106.7) 7 9.5 3 1.8 13.7 (1.6, 113.6)
X-ray pelvis 2 2.7 0 0.0 – – 2 2.7 1 0.6 – –
– – 16.2 18 10.7 3.2 (1.0, 10.8) 15 20.3 23 13.6 4.6 (1.2, 17.5)
ESR 6 8.1 1 0.6 14.3 (1.7, 120.8) 7 9.5 2 1.2 14.5 (1.8, 120.7)
MRI scan NA NA NA NA – – 0 0.0 2 1.2 – –
NSAIDs 52 70.3 70 41.4 3.6 (1.8, 7.1) 57 77.0 94 55.6 3.1 (1.4, 6.6)
Analgesics 37 50.0 53 31.4 2.0 (1.1, 3.6) 41 55.4 77 45.6 1.4 (0.8, 2.5)
Opioids 8 10.8 10 5.9 1.8 (0.7, 4.7) 10 13.5 13 7.7 1.8 (0.8, 4.2)
Tricyclic antidepressants 10 13.5 14 8.3 1.6 (0.7, 3.8) 12 16.2 20 11.8 1.3 (0.6, 3.0)
SSRI antidepressants 5 6.76 24 14.2 0.37 (0.1, 1.1) 9 12.16 33 19.5 0.51 (0.2, 1.2)
Features: Large Joint symptom codes relating to large limb joints (shoulder-wrist, hip-ankle); Other joint symptoms codes relating to joints distal to wrist/ ankle; ESR
Erythrocyte sedimentation rate, MRI Magentic resonance imaging, NSAID Non-steroidal anti-inflammatory drugs, Analgesics paracetamol, codeine, Opioids opioid
drugs of the potency of tramadol or higher, SSRI Selective Serotonin Reuptake Inhibitor & related antidepressants; Index date: date of diagnosis for cases, date of
diagnosis of matched case for controls
Table 4 Numbers, proportions and odds ratios (95% CI) for composite features in the three years before diagnosis of AS/index date
Comparison with population controls Comparison with symptomatic controls
Cases (N = 74) Controls (N = 296) Controls (N = 169)
Composite features N % N % OR (95% CI) N % OR (95% CI)
Axial pain within 30 days of NSAID 29 39.2 20 6.8 10.4 (4.9, 22.1) 45 26.6 1.8 (0.9, 3.6)
Axial pain within 360 days of large joint symptom 9 12.2 8 2.7 7.2 (2.2, 24.0) 11 6.5 1.5 (0.5, 4.2)
Axial pain separated by 180 days 17 23.0 7 2.4 12.7 (4.7, 34.6) 17 10.1 2.8 (1.3, 5.9)
Axial pain separated by 360 days 10 13.5 5 1.7 8.0 (2.7, 23.4) 11 6.5 2.2 (0.8, 5.6)
Axial pain, without ever sciatica 36 48.7 27 9.1 8.9 (4.7, 16.9) 82 48.5 1.1 (0.6, 1.9)
Tendon disorders separated by 180 days 1 1.4 1 0.3 – – 0 0.0 – –
Tendon disorder within 360 days of axial pain 6 8.1 2 0.7 21.7 (2.6, 181.5) 5 3.0 2.7 (0.8, 9.0)
FBC within 90 days of axial pain 7 9.5 4 1.4 8.6 (2.2, 33.6) 10 5.9 2.2 (0.7, 7.3)
ESR within 180 days of axial pain 4 5.4 0 0.0 – – 1 0.6 – –
Iritis within 360 days of axial pain 5 6.8 0 0.0 – – 0 0.0 – –
Feature names follow the format X relationship Y where relationship is defined as follows X within N days of Y – any occurrence of X within N days of any
occurrence of Y (in either order)
X separated by > N days – two consecutive occurrences of X separated by more than N days
X without ever Y – one or more occurrences of X and no occurrences of Y
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cases: distinct episodes of axial pain separated by more
than 6months (OR 12.7, 95% CI 4.5 to 34.6); the occur-
rence of axial pain with and tendon symptoms within
the same year (OR 21.7, 95% CI 2.6 to 181.5); and the
co-occurrence (within 30 days) of axial pain and a pre-
scription for nonsteroidal anti-inflammatory drug (OR
10.4, 95% CI 4.9 to 22.1).
Occurrence of diagnostic features over the time prior to
diagnosis
Figure 1 shows histograms of the number of years between
first episode of back pain or NSAID prescription and diag-
nosis (or matching) for cases and symptomatic controls.
The median time between first coded episode of back pain
and diagnosis of AS was 4 years (interquartile range 2 to 7).
For the same patients the median time between first pre-
scription for a NSAID was 4 years (interquartile range 2 to
6). Fig. 2 shows plots of eight diagnostic features, showing
the ORs for three-year time windows with different intervals
between the end of the three-year window and the diagnosis
/ matching date. Each plot compares cases with matched
population controls (in blue) and matched symptomatic
controls (in red). In all plots, 95% confidence intervals are
indicated by dotted lines. The comparison with population
controls demonstrates the development of features over
time. The comparison with symptomatic controls indicates
whether features have different predictive value in diagnos-
ing symptomatic patients at different stages.
The plot for axial pain shows that the odds ratio for
coded episodes of axial pain rose steadily from the 3 year
period ending 3 years before diagnosis to the 3 year
period ending at the time of diagnosis when compared
to population controls. On the other hand, the plots for
large joint symptoms and (in the 2 years prior to diagno-
sis) enthesopathy suggests little or no time trend. The
combination of axial pain and large joint symptoms –
while relatively infrequent – shows a strong signal begin-
ning at least 2 years before diagnosis.
Discussion
Summary of main findings
This study demonstrates new and potentially useful
composite features within electronic health records, such
as two or more distinct episodes of axial pain, which ap-
pear to have predictive value and may in turn lead to
earlier diagnosis.
Strengths and limitations
Our choice of features as pointers used principles of se-
lection based on expert input [15] and methods of data
Fig. 1 Histograms of number of years before diagnosis when back pain and NSAID prescription first present in electronic records
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consolidation and aggregation which have been devel-
oped for use with clinical data sources other than GP re-
cords [10, 16]. This sequence of steps is broadly
comparable with other recent approaches to the sum-
marisation of clinical data [16, 17]. We used an estab-
lished anonymised GP record set which contained both
diagnostic and symptom codes using the Read code for-
mat as well as prescribing data which means that the
method is transferrable to other datasets of primary care
data and potentially into clinical use.
There were limitations relating to the data. The first
was the small number of incident cases of AS. This
meant that confidence intervals were wide and it is pos-
sible that we lacked statistical power to detect some po-
tentially meaningful associations. The data was from
stand-alone primary care records with no linkage to
Fig. 2 Plots of odds ratio for individual features over three years, by gap between the end of the three year window and the date of diagnosis /
matching. Dotted lines indicate 95% confidence intervals for odds ratios
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secondary care records so we could not assess the reli-
ability of GPs’ diagnosis of AS, however in our experi-
ence GP practices tend not to code such diagnoses
without specialist opinion and in a recent US study a
over 80% of a sample of coded diagnoses of AS were
confirmed on chart review [18]. It should be noted that
the annual incidence (approximately 4 per 100,000 per
year in adults aged 18–60 years) is compatible with the
lifetime prevalence of approximately 15 per 10,000 ob-
served in other studies [19, 20]. The diagnostic criteria
for AS and the wider spondyloarthropathies evolved dur-
ing the exposure time period [21] and it is increasingly
recognised that disorders in the spondyloarthritis
spectrum are much more common than full AS [22].
The data on symptoms and investigations were more
sparse than anticipated with only around half of cases
having back pain coded in the 3 years prior to diagnosis.
This probably reflects the limited use of symptom codes
by GPs, even in this database where a reason for con-
sultation was meant to be given for each attendance. For
those cases where a code for axial pain was entered,
there were not long periods of GPs issuing NSAID pre-
scriptions prior to a symptom code. The use of diagnos-
tic tests was under-reported in the database, particularly
until around 2006 when the direct importing of labora-
tory tests into electronic records began being used
widely in contributing practices. While tests such as in-
flammatory markers have low predictive value, [23] the
fact that they were being carried out suggests GPs may
have had a raised index of suspicion for AS in at least
some patients.
Comparison with existing literature
Previous studies of the clinical features of AS have used pa-
tient self-report rather than entries coded in GP records [4,
5, 24]. One recent machine learning study used a broadly
similar range of single items from a different clinical dataset
[12] but did not explicitly code composites which were clin-
ically intuitive. We are not aware of studies which have
looked for combinations of features. Our analysis of the
emergence of clinical features over time confirms that in
some cases there is an observably long time to diagnosis
but also shows that the predictive value of clinical features
does increase with proximity to diagnosis [12].
Implications for research and practice
The ultimate purpose of this research is to identify clin-
ically useful predictors of a diagnosis of AS in order to
facilitate early diagnosis. None of the features examined
here are sufficient on their own, but merit examination
in a larger dataset. However some features (such as the
multiple episodes of axial pain) may be useful triggers to
clinicians to ask more specific questions about inflam-
matory back pain. Diagnostic support prompts are more
effective at the beginning of a consultation (influencing
the clinician’s prior probabilities and triggering specific
questions) than at the end [25] so computation of the
composite indicators of the kind we found, might not
need to be carried out in real-time, but could run during
quiet periods for the database and be used to inform fu-
ture consultations.
The next step in research is to repeat this work with a
larger, more recent and less sparse dataset. This should
be able to access more information about diagnostic
tests (through automatic transfer of results from labora-
tories to electronic records in general practice) and link-
age to hospital records (to confirm diagnosis).
Additionally, machine learning techniques [12, 26, 27]
have potential value in feature reduction and model se-
lection. Ultimately the aim must be to apply these obser-
vations within predictive models for earlier referral and
diagnosis of AS.
Conclusion
We have developed and tested conventional and new
composite pointers to a diagnosis of ankylosing spondyl-
itis in GP records. Some of these were present several
years before the diagnosis and may be valuable targets
for systems to support earlier diagnosis.
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